Dr. Trace Curry performs first 2 commercial Allurion Swallowable Gastric Balloons in the US! Learn more...

Additional menu

JourneyLite – Weight Loss Surgery & Medical Weight Management

Lasting Weight Loss Starts Here!

Login

Button

Contact Us
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
You are here: Home / Education / Foundayo vs. Zepbound: Is the New Weight Loss Pill Better Than the Shot?
A visually informative comparison infographic banner on a bright medical countertop. The center shows oral capsules in a small dish (labeled "FOUNDAYO") next to an injectable pen and vial (labeled "ZEPBOUND"), separated by "VS" text. "FOUNDAYO" includes a downward bar chart graphic, and "ZEPBOUND" includes a downward scatter plot graphic. The blurred background features a medical monitor displaying downward health charts on the left and a person with a measuring tape on the right.

by

Foundayo vs. Zepbound: Is the New Weight Loss Pill Better Than the Shot?

The “Pill” Revolution: Why Foundayo is a Total Game-Changer for Weight Loss

By Trace Curry, MD, FASMBS

Dr. Trace Curry, MD, FASMBS – Board-Certified Bariatric Surgeon and Medical Director of JourneyLite in Cincinnati

Dr. Trace Curry is the Medical Director and Founder of JourneyLite Physicians and JourneyLite Surgery Center

For years, when patients came into my office asking for the breakthrough weight loss results of GLP-1s, the conversation sometimes hit a snag, otherwise known as “the needle.” While many have embraced weekly injections like Zepbound and Wegovy, a significant number of you have been waiting for the “Holy Grail”—a simple daily pill that actually works.

Well, as of today, the wait may be over. With the FDA approval of Eli Lilly’s Foundayo (orforglipron), we are entering a brand-new era of metabolic medicine. Here is everything you need to know about how this medication works, how it stacks up against the “big names,” and what it will cost you.

What Makes Foundayo Different?

Most GLP-1 medications (like semaglutide or tirzepatide) are peptides. Think of peptides like fragile strings of proteins; if you swallow them, your stomach acid destroys them before they can get into your bloodstream. This is why we’ve had to rely on injections.

Foundayo is different because it is a “small-molecule” GLP-1 receptor agonist.  Compared to WeGovy and Zepbound, it’s chemically sturdy enough to survive your digestive system without a special coating or restricted fasting rules (as with the Wegovy pill).  So you don’t have to wait 30 minutes after taking it like you do with oral forms of semaglutide.

How Does it Compare? 

The question everyone asks is: “Will a pill lose me as much weight as the shot?” The data from the ATTAIN-1 clinical trials is impressive. While the “heavy hitters” like Zepbound (tirzepatide) still hold the crown for total percentage lost, Foundayo is performing remarkably well, especially for a non-injectable.

Weight Loss Comparison Table

  • Zepbound (weekly injection)
    • Mechanism: GLP-1+GIP
    • Average Weight Loss: 21-22%
  • Wegovy (injection)
    • Mechanism: GLP-1 only
    • Average Weight Loss: 15%
  • Wegovy (daily pill)
    • Mechanism: GLP-1 only
    • Average Weight Loss: 21-22%
  • Foundayo (daily pill)
    • Mechanism: GLP-1 only
    • Average Weight Loss: 12.5-15%

Doctor’s Note: Don’t let the 15% vs 22% gap discourage you. For many patients, losing 15% of body weight is life-altering—reversing sleep apnea, lowering blood pressure, and getting off “maintenance” medications. Foundayo offers a “sweet spot” of high efficacy and zero needles.

The GLP-1 Evolution

To understand why Foundayo is such a milestone, it helps to see how far we’ve come in just a few short years.

The Peptide Era: 2021-2023

Wegovy and Zepbound dominate the market. High efficacy, but limited by cold-chain shipping requirements and needle-phobia.

The Supply Crisis: 2024-2025

Manufacturing injectables is complex. Shortages become common as demand outstrips the ability to fill pens.

The Small-Molecule Breakthrough: April 2026

Foundayo (orforglipron) is approved. Because it’s a pill, it can be manufactured in traditional facilities, drastically increasing supply and lowering costs.

Is it Affordable?

This is perhaps the best news of all. Because pills are significantly cheaper to manufacture, package, and ship than refrigerated glass injectors, Eli Lilly is passing those savings on to you.

  • Self-Pay/Uninsured: Lilly has set the “LillyDirect” price at $149 per month. Compare that to the $500+ sticker price for Wegovy or Zepbound, and you can see why this is a game-changer.
  • With Insurance: For those with commercial coverage, co-pay cards can bring the cost down to as low as $25 per month.

Is Foundayo Right For You?

If you have a BMI over 30 (or over 27 with a condition like high blood pressure), Foundayo could be a fantastic tool. It’s especially ideal for:

  • Frequent Travelers: No need to worry about keeping pens cold on a plane.
  • Needle-Averse Patients: If the “ick factor” of a shot has kept you away, this barrier is gone.
  • Maintenance: It may become a preferred option for patients who lost weight on Zepbound and want an easier, cheaper daily pill to maintain their results long-term.

As always, my team and I are here to help you navigate these options. The “best” medication is the one that fits your lifestyle, your budget, and your biology. If you’re interested in learning more, click here to schedule a consultation!